1-4 of 4
Tracy Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO3-06-09: A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer

David Page, Alexander Hall, Krystle Collins, Nicole Moxon, Staci Mellinger, Tracy Kelly, Aysha Kelley, Nicole Fredrich, Amanda Seino, Gabriella Liberatore, Alison Conlin, Zheng Topp, Kelly Perlewitz, Sasha Stanton, Walter Urba, Yaping Wu, Maritza Martel, Zhaoyu Sun, Yoshinobu Kogushi, William Redmond, Tiffany Traina, Ayca Guculp
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-06-09.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-06-09
Published: 02 May 2024
View article titled, Abstract PO3-06-09: A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer
Journal Articles

Abstract PO2-03-10: Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial

David Page, Alan Su, Nicole Moxon, Staci Mellinger, Tracy Kelly, Nicole Fredrich, Amanda Seino, Zheng Topp, Philippa Newell, Kristen Massimino, Shaghayegh Aliabadi, Yaping Wu, Maritza Martel, William Redmond, Yoshinobu Kogushi, Grace Mcgee, Alejandra Mendez-Torres, Zhaoyu Sun, James Imatani, Alison Conlin, Kelly Perlewitz, Tyler Nielsen, Sasha Stanton
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-03-10.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-03-10
Published: 02 May 2024
View article titled, Abstract PO2-03-10: Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial
Journal Articles

Abstract P1-15-17: Sustained acceptable cosmetic outcomes and local control following accelerated partial breast irradiation using CT-guided IMRT in the prone position: Results from a phase I/II feasibility study

Carmen Bergom, Phillip Prior, Kristofer Kainz, Natalya V Morrow, Ergun E Ahunbay, Alonzo Walker, X Allen Li, Tracy Kelly, Adam D Currey, Julia White
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P1-15-17.
https://doi.org/10.1158/1538-7445.SABCS14-P1-15-17
Published: 01 May 2015
View article titled, Abstract P1-15-17: Sustained acceptable cosmetic outcomes and local control following accelerated partial breast irradiation using CT-guided IMRT in the prone position: Results from a phase I/II feasibility study
Journal Articles

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A. Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric Bernstein, Rachel Sanborn, Walter J. Urba, Andrew D. Weinberg
Journal: Cancer Research
Cancer Res (2013) 73 (24): 7189–7198.
https://doi.org/10.1158/0008-5472.CAN-12-4174
Published: 16 December 2013
View article titled, OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Open the PDF for OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients in another window
Includes: Supplementary data